BR112012025654A2 - seleção e uso de células hospedeiras para produção de glicoproteína - Google Patents
seleção e uso de células hospedeiras para produção de glicoproteínaInfo
- Publication number
- BR112012025654A2 BR112012025654A2 BR112012025654A BR112012025654A BR112012025654A2 BR 112012025654 A2 BR112012025654 A2 BR 112012025654A2 BR 112012025654 A BR112012025654 A BR 112012025654A BR 112012025654 A BR112012025654 A BR 112012025654A BR 112012025654 A2 BR112012025654 A2 BR 112012025654A2
- Authority
- BR
- Brazil
- Prior art keywords
- selection
- host cells
- electron beam
- glycoprotein production
- microfocus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- X-Ray Techniques (AREA)
Abstract
elemento de catálogo para um tubo de raios-x microfoco. um elemento de catálogo para um tubo de raios-x microfoco compreende um filamento que consiste de fio aquecível para emissão termiônica de elétrons para formar um feixe de elétrons. o filamento compreende em uma região de fonte do feixe de elétrons uma extensão alongada (11, 12) em cada uma das duas direções perpendiculares ao feixo de elétrons.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32186310P | 2010-04-07 | 2010-04-07 | |
PCT/US2011/031641 WO2011127325A1 (en) | 2010-04-07 | 2011-04-07 | Selection and use of host cells for production of glycoproteins |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012025654A2 true BR112012025654A2 (pt) | 2017-07-18 |
Family
ID=44763294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012025654A BR112012025654A2 (pt) | 2010-04-07 | 2011-04-07 | seleção e uso de células hospedeiras para produção de glicoproteína |
Country Status (8)
Country | Link |
---|---|
US (1) | US20130123126A1 (pt) |
EP (1) | EP2555801A4 (pt) |
CN (1) | CN102917733A (pt) |
AU (1) | AU2011237445B2 (pt) |
BR (1) | BR112012025654A2 (pt) |
CA (1) | CA2794709A1 (pt) |
MX (1) | MX2012011647A (pt) |
WO (1) | WO2011127325A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2602108T3 (es) | 2010-04-07 | 2017-02-17 | Momenta Pharmaceuticals, Inc. | Método para cuantificar glicoformas que contienen alta manosa |
CN103782168B (zh) | 2011-03-12 | 2016-03-16 | 动量制药公司 | 在糖蛋白产品中包含n-乙酰己糖胺的n-聚醣 |
WO2013181576A2 (en) * | 2012-06-01 | 2013-12-05 | Momenta Pharmaceuticals, Inc. | Methods of evaluating and making biologics |
WO2013181575A2 (en) | 2012-06-01 | 2013-12-05 | Momenta Pharmaceuticals, Inc. | Methods related to denosumab |
US20150125848A1 (en) * | 2012-06-01 | 2015-05-07 | Momenta Pharmaceuticals, Inc. | Methods related to alemtuzumab |
WO2014149067A1 (en) | 2013-03-15 | 2014-09-25 | Momenta Pharmaceuticals, Inc. | Methods related to ctla4-fc fusion proteins |
WO2014186310A1 (en) | 2013-05-13 | 2014-11-20 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
EP3058084A4 (en) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
CA2936831A1 (en) * | 2014-01-13 | 2015-07-16 | Sergey SHULGA-MORSKOY | Method for optimizing post-translational modifications on recombinant proteins |
US11719704B2 (en) | 2015-12-30 | 2023-08-08 | Momenta Pharmaceuticals, Inc. | Methods related to biologics |
JP7415771B2 (ja) * | 2020-04-24 | 2024-01-17 | 株式会社島津製作所 | 分析支援装置、分析支援方法および分析支援プログラム |
CN111518825B (zh) * | 2020-04-30 | 2022-10-11 | 浙江工业大学 | 一种多基因组合表达制备蛹虫草多糖的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047335A (en) * | 1988-12-21 | 1991-09-10 | The Regents Of The University Of Calif. | Process for controlling intracellular glycosylation of proteins |
CN1314913A (zh) * | 1998-06-10 | 2001-09-26 | 格里科设计公司 | 有针对性的组合化合物库及其进行筛选所用的高效测定方法 |
US6949372B2 (en) * | 1999-03-02 | 2005-09-27 | The Johns Hopkins University | Engineering intracellular sialylation pathways |
CA2459040A1 (en) * | 2001-09-14 | 2003-03-27 | Mimeon, Inc. | Methods of making glycolmolecules with enhanced activities and uses thereof |
ATE430580T1 (de) * | 2001-10-25 | 2009-05-15 | Genentech Inc | Glycoprotein-zusammensetzungen |
MXPA05010773A (es) * | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos. |
US20060127950A1 (en) * | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
US20060252672A1 (en) * | 2005-04-05 | 2006-11-09 | Betenbaugh Michael J | Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation |
CA2682578C (en) * | 2007-04-03 | 2015-05-26 | Oxyrane Uk Limited | Glycosylation of molecules |
EP2528002B1 (en) * | 2007-04-16 | 2015-11-04 | Momenta Pharmaceuticals, Inc. | Defined glycoprotein products and related methods |
WO2008128230A1 (en) * | 2007-04-16 | 2008-10-23 | Momenta Pharmaceuticals, Inc. | Reference glycoprotein products and related methods |
US8338088B2 (en) * | 2007-04-16 | 2012-12-25 | Momenta Pharmaceuticals, Inc. | Methods related to cell surface glycosylation |
US8084222B2 (en) * | 2008-09-26 | 2011-12-27 | Eureka Therapeutics, Inc. | Methods for generating host cells |
-
2011
- 2011-04-07 US US13/637,972 patent/US20130123126A1/en not_active Abandoned
- 2011-04-07 BR BR112012025654A patent/BR112012025654A2/pt not_active IP Right Cessation
- 2011-04-07 CA CA2794709A patent/CA2794709A1/en not_active Abandoned
- 2011-04-07 MX MX2012011647A patent/MX2012011647A/es active IP Right Grant
- 2011-04-07 WO PCT/US2011/031641 patent/WO2011127325A1/en active Application Filing
- 2011-04-07 CN CN2011800223220A patent/CN102917733A/zh active Pending
- 2011-04-07 AU AU2011237445A patent/AU2011237445B2/en not_active Ceased
- 2011-04-07 EP EP11766762.6A patent/EP2555801A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2555801A1 (en) | 2013-02-13 |
US20130123126A1 (en) | 2013-05-16 |
AU2011237445B2 (en) | 2016-03-24 |
CN102917733A (zh) | 2013-02-06 |
EP2555801A4 (en) | 2014-02-26 |
CA2794709A1 (en) | 2011-10-13 |
MX2012011647A (es) | 2012-11-29 |
WO2011127325A1 (en) | 2011-10-13 |
AU2011237445A1 (en) | 2012-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012025654A2 (pt) | seleção e uso de células hospedeiras para produção de glicoproteína | |
EP3168856A3 (en) | X-ray sources using linear accumulation | |
EP4295970A3 (en) | X-ray device and structure manufacturing method | |
BR112014019198A8 (pt) | Sistema de imagiologia de múltiplas vistas de transmissão e espalhamento combinado | |
IL241897A (en) | Pro-electric emitter for electron beam emission and radiation production | |
BR112013031049A2 (pt) | tubo de raios x para gerar radiação de raios x, sistema de obtenção de imagem por raios x, método para gerar um feixe de raios x de múltipla energia, uso de uma unidade de filtro para a geração da radiação de raios x de múltipla energia, elemento de programa de computador para controlar um aparelho e meio legível em computador | |
WO2014116665A3 (en) | Directed x-ray fields for tomosynthesis | |
CL2016000009A1 (es) | Tratamiento de rosacea papulopustular con ivermectina. | |
BR112017004114A2 (pt) | torre de transmissão de energia | |
EP3479392A4 (en) | HIGH BRIGHTNESS BORED ELECTRON BEAM EMITTERS FOR USE IN A VACUUM | |
EP3154433A4 (en) | Radiography and computed tomography with high-energy electron beams | |
BR112018006103A2 (pt) | aplicador de precisão | |
CL2016002794A1 (es) | Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico | |
IL267375A (en) | Electron beam emitters with ruthenium coating | |
EP2997612A4 (en) | Actinic and electron beam radiation curable water based electrode binders and electrodes incorporating same | |
BR112012031770A2 (pt) | pano não tecido reforçado | |
WO2012119009A3 (en) | Electron beam source system and method | |
PE20161158A1 (es) | Aparato y metodo de apoyo en tierra | |
BR112017002496A2 (pt) | agente de controle contra a síndrome reprodutiva e respiratória porcina | |
BR112018003238A2 (pt) | seleção de pacientes para terapia de combinação | |
BR112017006511A2 (pt) | método para produção de uma manta de espuma | |
EP3033761A4 (en) | Dual tube support for electron emitter | |
CY1122725T1 (el) | Αποσμητικη συνθεση που περιλαμβανει ενα μειγμα αλφα, βητα και γαμμα κυκλοδεξτρινων | |
CL2016001627A1 (es) | Polvo de carbón conductor, método para la fabricación del mismo y uso del mismo | |
BR112019005825A2 (pt) | vírus envelopado modificado, composição farmacêutica, e, método para tratar um câncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |